MK-677 (Ibutamoren) vs Oxytocin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

MK-677 (Ibutamoren)

MK-677, also known as Ibutamoren, is an orally active growth hormone secretagogue. Unlike peptides, it can be taken orally and has a long half-life, providing 24-hour GH elevation.

Full details →

Oxytocin

Oxytocin is a natural hormone produced in the hypothalamus, often called the 'love hormone' or 'bonding hormone.' It plays key roles in social bonding, childbirth, lactation, and stress regulation.

Full details →

Side-by-Side Comparison

AspectMK-677 (Ibutamoren)Oxytocin
MechanismActs as a potent, selective agonist of the ghrelin receptor (GHS-R1a). Increases GH and IGF-1 levels without affecting cortisol. Mimics ghrelin's GH-releasing effects.Binds to oxytocin receptors in the brain and peripheral tissues. Promotes social bonding, reduces anxiety and stress response, and has various peripheral effects on smooth muscle contraction.
Typical DosageTypical dosing: 10-25mg taken orally once daily. Often taken at night due to sleep benefits and appetite increase.Intranasal: 20-40 IU (international units) for social/anxiolytic effects. Clinical uses (labor induction) require IV administration under medical supervision.
AdministrationOral administration (capsule or liquid). Can be taken with or without food. Long half-life allows once-daily dosing.Intranasal spray for behavioral effects. IV only in clinical settings. Sublingual also possible. Best used situationally rather than continuously.
Side EffectsIncreased appetite and water retention are most common. May cause lethargy, vivid dreams, and mild numbness. Can affect blood glucose and insulin sensitivity.Intranasal: headache, nasal irritation, drowsiness. May cause over-attachment or emotional sensitivity. IV (clinical): uterine hyperstimulation, water retention.
Best For

What They Have in Common

Both MK-677 (Ibutamoren) and Oxytocin are commonly used for:

Key Differences

Ready to Learn More?